Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer vaccines

D M Pardoll1

  • 1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Trends in Pharmacological Sciences
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Cancer immunotherapy, a century after its inception, shows promise with new molecular vaccine approaches. Identifying tumor-specific antigens is key to developing targeted cancer vaccines for effective therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.

Mucosal immunology·2016
Same author

Comparative analysis of paracrine immunotherapy in experimental brain tumors.

Neurosurgical focus·2006
Same author

Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines.

Vaccine·2002
Same author

Immunology. Stress, NK receptors, and immune surveillance.

Science (New York, N.Y.)·2001
Same author

Antigen-specific blockade of T cells in vivo using dimeric MHC peptide.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • William Coley's 1893 report marked the centenary of using bacterial toxins for immune-mediated tumor regression.
  • Despite early promise, active immunotherapy has not yet become a standard cancer treatment modality.
  • Recent advancements focus on molecular vaccine approaches grounded in immunological principles.

Purpose of the Study:

  • To review emerging molecular vaccine strategies for cancer therapy.
  • To highlight approaches demonstrating improved systemic anti-tumor effects in preclinical models.
  • To discuss the future potential of antigen-specific cancer vaccines.

Main Methods:

  • Review of recent literature on molecular cancer vaccine development.
  • Analysis of studies employing rational immunological principles.

Related Experiment Videos

  • Examination of preclinical data from animal models showing anti-tumor effects.

    • Main Results:

    • Newer molecular vaccine approaches show improved systemic anti-tumor effects in animal models.
    • These strategies are based on established immunological principles.
    • The field is moving towards more targeted and specific therapeutic interventions.

    Conclusions:

    • Molecular vaccine strategies represent a promising evolution in active cancer immunotherapy.
    • The identification of tumor-specific antigens is crucial for developing targeted, effective cancer vaccines.
    • Further research in this area holds significant potential for future cancer treatment.